EUVIMEDEUVIMED entdecken
Crossref

Untargeted metabolomics predicts delayed elimination of methotrexate in pediatric patients with intracranial tumors

Journal of Chinese Pharmaceutical Sciences · 30.04.2026 · 35 (4) · 329

DOI: 10.5246/jcps.2026.04.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chinese Pharmaceutical Sciences, online erschienen am 10.04.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Untargeted metabolomics predicts delayed elimination of methotrexate in pediatric patients with intracranial tumors. Journal of Chinese Pharmaceutical Sciences, 35(4), 329. https://doi.org/10.5246/jcps.2026.04.022

Vancouver

Untargeted metabolomics predicts delayed elimination of methotrexate in pediatric patients with intracranial tumors. Journal of Chinese Pharmaceutical Sciences. 2026;35(4):329. doi:10.5246/jcps.2026.04.022

BibTeX
@article{euvimed2026,
  title = {Untargeted metabolomics predicts delayed elimination of methotrexate in pediatric patients with intracranial tumors},
  journal = {Journal of Chinese Pharmaceutical Sciences},
  year = {2026},
  volume = {35},
  number = {4},
  pages = {329},
  doi = {10.5246/jcps.2026.04.022}
}
Kostenlos starten →